InsiderTrades.com logo

IRD Insider Trading

Insider Ownership Percentage: 6.60%
Insider Buying (Last 12 Months): $98,000.00
Insider Selling (Last 12 Months): $0.00

Opus Genetics Insider Trading History Chart

This chart shows the insider buying and selling history at Opus Genetics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Opus Genetics Share Price & Price History

Current Price: $2.23
Price Change: ▲ Price Increase of +0.14 (6.70%)
As of 12/4/2025 05:00 PM ET

This chart shows the closing price history over time for IRD up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Opus Genetics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/26/2024George MagrathCEOBuy100,000$0.98$98,000.00599,150View SEC Filing Icon  
11/18/2024George MagrathCEOBuy9,706$1.02$9,900.12492,950View SEC Filing Icon  
11/15/2024George MagrathCEOBuy90,294$1.01$91,196.94483,244View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Opus Genetics (NASDAQ:IRD)

14.97% of Opus Genetics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at IRD by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Opus Genetics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/20/2025Voss Capital LP562,377$0.93M0.0%+3.9%0.815%Search for SEC Filing on Google Icon
11/17/2025Mink Brook Asset Management LLC1,237,947$2.04M1.4%+3.4%1.904%Search for SEC Filing on Google Icon
11/17/2025Citadel Advisors LLC113,416$0.19M0.0%+496.9%0.174%Search for SEC Filing on Google Icon
11/14/2025Creative Planning128,366$0.21M0.0%N/A0.197%Search for SEC Filing on Google Icon
11/14/2025Raymond James Financial Inc.22,508$37K0.0%+95.6%0.035%Search for SEC Filing on Google Icon
11/14/2025Two Sigma Investments LP108,338$0.18M0.0%+169.6%0.167%Search for SEC Filing on Google Icon
11/7/2025Vanguard Group Inc.1,342,025$2.21M0.0%+35.3%2.240%Search for SEC Filing on Google Icon
8/15/2025Opaleye Management Inc.1,220,000$1.15M0.2%+3.8%2.045%Search for SEC Filing on Google Icon
8/15/2025Mink Brook Asset Management LLC1,197,616$1.13M1.0%+47.8%2.007%Search for SEC Filing on Google Icon
8/15/2025Bridgeway Capital Management LLC42,065$40K0.0%-63.9%0.071%Search for SEC Filing on Google Icon
8/14/2025Nantahala Capital Management LLC3,345,923$3.15M0.1%+6.0%5.608%Search for SEC Filing on Google Icon
8/14/2025Voss Capital LP541,159$0.51M0.0%+260.8%0.907%Search for SEC Filing on Google Icon
8/12/2025BIOS Capital Management LP3,683,429$3.46M4.8%+270.1%6.174%Search for SEC Filing on Google Icon
5/16/2025AWM Investment Company Inc.524,245$0.52M0.1%N/A1.153%Search for SEC Filing on Google Icon
5/15/2025Nantahala Capital Management LLC3,157,895$3.10M0.1%N/A6.943%Search for SEC Filing on Google Icon
5/15/2025Royal Bank of Canada304,123$0.30M0.0%N/A0.669%Search for SEC Filing on Google Icon
5/14/2025BIOS Capital Management LP995,249$0.98M1.2%N/A2.188%Search for SEC Filing on Google Icon
5/14/2025Comerica Bank30,000$29K0.0%N/A0.066%Search for SEC Filing on Google Icon
5/14/2025Mink Brook Asset Management LLC810,080$0.80M0.8%N/A1.781%Search for SEC Filing on Google Icon
5/14/2025Voss Capital LP150,000$0.15M0.0%N/A0.330%Search for SEC Filing on Google Icon
5/12/2025Virtu Financial LLC26,275$26K0.0%N/A0.058%Search for SEC Filing on Google Icon
5/5/2025Kestra Private Wealth Services LLC48,341$47K0.0%N/A0.106%Search for SEC Filing on Google Icon
5/2/2025Apollon Wealth Management LLC28,089$28K0.0%N/A0.062%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Opus Genetics logo
Opus Genetics Inc. is a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of unmet needs of patients with refractive and retinal eye disorders. Opus Genetics Inc., formerly known as Ocuphire Pharma Inc., is based in Farmington Hills, Michigan.
Read More on Opus Genetics

Today's Range

Now: $2.23
Low: $2.06
High: $2.29

50 Day Range

MA: $1.97
Low: $1.65
High: $2.30

52 Week Range

Now: $2.23
Low: $0.65
High: $2.37

Volume

382,855 shs

Average Volume

452,423 shs

Market Capitalization

$153.78 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.42

Who are the company insiders with the largest holdings of Opus Genetics?

Opus Genetics' top insider shareholders include:
  1. George Magrath (CEO)
Learn More about top insider investors at Opus Genetics.

Who are the major institutional investors of Opus Genetics?

Opus Genetics' top institutional shareholders include:
  1. Vanguard Group Inc. — 2.24%
  2. Mink Brook Asset Management LLC — 1.90%
  3. Voss Capital LP — 0.82%
  4. Creative Planning — 0.20%
  5. Citadel Advisors LLC — 0.17%
  6. Two Sigma Investments LP — 0.17%
Learn More about top institutional investors of Opus Genetics stock.

Which institutional investors are buying Opus Genetics stock?

During the previous quarter, IRD stock was purchased by institutional investors including:
  1. Vanguard Group Inc.
  2. Creative Planning
  3. Citadel Advisors LLC
  4. Two Sigma Investments LP
  5. Mink Brook Asset Management LLC
  6. Voss Capital LP
  7. Raymond James Financial Inc.